Epiterna SA
Longevity company based on cellular reprogramming.
Longevity company based on cellular reprogramming. We would like to discover drug to extend lifespan and healthspan. The science will be based on cellular rejuvenation and reprogramming, a new method to erase the damages associated with aging in vitro.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
No news
No milestones
No Jobs
No videos and documents
No Awards
Epiterna SA
Longevity company based on cellular reprogramming.
Headquarter:
Epalinges
Foundation Date:
June 2022
Technology:
- Biotech
Sectors:
- Drug discovery